Page last updated: 2024-10-28

gyki 52466 and Body Weight

gyki 52466 has been researched along with Body Weight in 2 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.

Research Excerpts

ExcerptRelevanceReference
" They were found fairly potent in rat tail flick and mouse phenylquinone writhing assays but the dose-response curves were rather shallow as compared to that of morphine."1.30Apparent antinociceptive and anti-inflammatory effects of GYKI 52466. ( Kedves, R; Máté, I; Székely, JI; Tarnawa, I; Török, K, 1997)
" In this study, neuroprotection derived from acute administration of the non-NMDA antagonist GYKI 52466, and chronic administration of the non-NMDA antagonist CNQX was examined in order to determine the potential roles of non-NMDA receptors in the observed neurodegeneration."1.30The neuroprotective effects of non-NMDA antagonists in the cerebellum of the spastic Han Wistar mutant. ( Cohen, RW; Hernandez, CM; Nisim, AA, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Székely, JI1
Kedves, R1
Máté, I1
Török, K1
Tarnawa, I1
Nisim, AA1
Hernandez, CM1
Cohen, RW1

Other Studies

2 other studies available for gyki 52466 and Body Weight

ArticleYear
Apparent antinociceptive and anti-inflammatory effects of GYKI 52466.
    European journal of pharmacology, 1997, Oct-08, Volume: 336, Issue:2-3

    Topics: Acetaminophen; Analgesics; Animals; Anti-Anxiety Agents; Anti-Inflammatory Agents; Arthritis, Experi

1997
The neuroprotective effects of non-NMDA antagonists in the cerebellum of the spastic Han Wistar mutant.
    Developmental neuroscience, 1999, Volume: 21, Issue:1

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Age Factors; Animals; Anti-Anxiety Agents; Behavior, Animal; B

1999